Enzolytics Inc (ENZC)

[B7$4]

Can anyone confirm if this ENZC CEO is the same Harry H. Zhabilov that was in charge of Immunotech Laborator (IMMB) that was suspended by the SEC back in 2014?

https://investorshub.advfn.com/Immunotech-Laboratories-Inc-IMMB-14943/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=108955578
https://investorshub.advfn.com/boards/replies.aspx?msg=122252748


http://immunotechlab.com/about-us/


https://www.bloomberg.com/profile/person/16555458
https://www.marketscreener.com/business-leaders/Harry-Zhabilov-006HVV-E/biography/

About Immunotech Laboratories Inc
Immunotech Laboratories, Inc. is a drug development company. The Company offers a drug platform, Irreversible Pepsin Fraction (IPF), which is a technology that can be used to facilitate a range of applications. Its flagship compound Immune Therapeutic Vaccine-1 (ITV-1) is a suspension of IPF, which is used in the treatment of human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) and Hepatitis C viruses and to modulate the immune system. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. The IPF modulates helper T1 cells expression of elaborate cytokines interferon (INF)-gamma, interleukin-2 (IL-2), which selectively promotes cell-mediated immune response and subsequently stimulates cytotoxic lymphocytes. The Company's other compounds in its pipeline include ITV-2 prenatal, ITV-3 Pediatric and ITV-4 HIV Vaccine.